COMMUNIQUÉS West-GlobeNewswire

-
Bavarian Nordic A/S Announces Major Shareholder Notification from Johnson & Johnson Innovation - Inc.
22/08/2017 -
Shire plc : Director/PDMR Shareholding
22/08/2017 -
Information about ongoing discussions and negotiations concerning out-licensing of Xbrane Biopharma AB's (publ) products
22/08/2017 -
Bavarian Nordic A/S - Articles of Association
22/08/2017 -
Phase 1 trials for two novel treatments of obesity and/or diabetes initiated by Zealand partner Boehringer Ingelheim
22/08/2017 -
Lubrizol LifeSciences Announces Vesta Expansion
22/08/2017 -
Shire plc : Director/PDMR Shareholding
22/08/2017 -
Medtronic Reports First Quarter Financial Results
22/08/2017 -
AC IMMUNE DISCOVERS NEXT-GENERATION ANTIBODIES FOCUSED ON NEURODEGENERATIVE DISEASES
22/08/2017 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
22/08/2017 -
Solon Eiendom ASA : Invitation to presentation of second quarter 2017 results
22/08/2017 -
Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September
22/08/2017 -
Herantis Pharma's Manager's Transactions
22/08/2017 -
Herantis Pharma's Manager's Transactions
22/08/2017 -
Herantis Pharma's Manager's Transactions
22/08/2017 -
Herantis Pharma's Manager's Transactions
22/08/2017 -
Herantis Pharma's Manager's Transactions
22/08/2017 -
Bavarian Nordic Announces Closing of Transaction with Janssen Pharmaceuticals, Inc. and Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.
21/08/2017 -
Sanofi : Disclosure of trading in own shares
21/08/2017
Pages